Publisher
Springer Berlin Heidelberg
Reference28 articles.
1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (2007) The montreal definition and classification of gastroesophageal reflux disease: a global. Evidence-based consensus paper. Z Gastroenterol 45:1125–1140
2. Delshad SD, Almario CV, Chey WD, Spiegel BMR (2020) Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms. Gastroenterology 158:1250–1261.e2
3. Nocon M, Keil T, Willich SN (2006) Prevalence and sociodemographics of reflux symptoms in Germany–results from a national survey. Aliment Pharmacol Ther 23:1601–1605
4. Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K, Willich SN (2012) Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care–the ProGERD study. Aliment Pharmacol Ther 35:154–164
5. Eusebi LH, Ratnakumaran R, Yuan Y et al (2018) Global prevalence of, and risk factors for, gastro- oesophageal reflux symptoms: a meta-analysis. Gut 67:430–440